Public Private Partnerships In this Category Solving the Health Equation: Improving Public and Private Contributions to Bridge the Gap Between Rich and Poor CountriesSeptember 3, 2006Type/Items(s): Financing Health Systems, Public Private Partnerships A local Indian public health care practitioner administering an oral polio vaccine dosage to a child in an outside setting, in one of the country's many villages. Image courtesy of The Public Health Image Library (PHIL) http://phil.cdc.gov/Phil/, Chris Zahniser. One of the major talking points of this conference is that funds and programmes aimed at those most in need are not reaching their intended target. There is widespread agreement that urgent action is needed to improve access to health for billions of poor people in developing countries. Despite vast investment, largely on the part of governments and international bodies but also by donors and companies seeking to honour a commitment to corporate social responsibility, it is widely acknowledged that precious few inroads are being made. More... PL05 - Global Gaps in Research, Capacity Building and Human ResourcesSeptember 1, 2006Type/Items(s): Track V Capacity Building and Partnerships, Public Private Partnerships Image: Dominic Monnier Plenary V addressed the current challenges and conditions for effective capacity building in the health workforce as well as medical research to improve health and give access to health care in developing countries. More... PL03 - Public-Private Partnerships: Exploring the FrameworksAugust 31, 2006Type/Items(s): Public Private Partnerships Image: Jorge Garbino, ICVolontaires.org To tackle global health problems that disproportionately affect the poor, the skills and expertise of the private as well as the public sectors are needed; thus, Public and Private Partnerships (PPP's), which sharply increased in number between 1995 and 2005. As one of the speakers, Dr. Roy Widdus, said, "They can be seen as valuable 'social experiments' which achieve synergy through complementarity" and most of all "to which few, if any, realistic alternatives exist". The plenary session that took place this afternoon at the Geneva Forum comprehensively addressed the issues arising from PPPs. More... Access to Health and Public-Private PartnershipsInterview with Dr. Imtiaz Jehan, Aga Khan University, Karachi, PakistanAugust 30, 2006Type/Items(s): Equity in Access to Health, Public Private PartnershipsAs a medical doctor, working in the field of maternal and neonatal health, Dr. Imtiaz Jehan sees public-private partnerships and the challenges related to access to health from a Southern perspective. She shares with us how she believes progress can be made for the public and the private sectors to working together. More... SY 11 - Public-Private Partnerships: Beneficial or Undermining?August 30, 2006Type/Items(s): Track I Access to Health Systems, Public Private PartnershipsIn order to answer this controversial and challenging question, the three speakers explained some of the benefits but also the drawbacks of PPP's, each one focusing on particular issues. What conditions lead to efficient PPP's? Should we reject PPP's all together? Should governments do more in terms of Research and Development (R&D)? There are no straightforward answers but the speakers came up with convincing and very interesting solutions. More... PS01 - Improving Access to Quality Medicines: Health Partnerships for the Developing World and the Fight Against CounterfeitingSolutions to Counteract the Lack of Access to Quality Health Care in Developing CountriesJuly 31, 2006Type/Items(s): Malaria, Tuberculosis, Track III Access to Drugs, Vaccines and Diagnosis, Public Private Partnerships, Neglected Diseases, HIV/AIDSThe availability of quality and non-counterfeit drugs is an essential part of any health care delivery service. This session presented the audience with information related to the expansion of private-public partnerships (PPPs) for the development of safe drugs and of drugs for neglected diseases. The speakers also pointed out the danger of counterfeit drugs and the efforts undertaken to combat this serious and life threatening menace. More... |  |
